rofecoxib has been researched along with Histiocytic Sarcoma in 1 studies
Histiocytic Sarcoma: Malignant neoplasms composed of MACROPHAGES or DENDRITIC CELLS. Most histiocytic sarcomas present as localized tumor masses without a leukemic phase. Though the biological behavior of these neoplasms resemble lymphomas, their cell lineage is histiocytic not lymphoid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reichle, A | 1 |
| Vogt, T | 1 |
| Kunz-Schughart, L | 1 |
| Bretschneider, T | 1 |
| Bachthaler, M | 1 |
| Bross, K | 1 |
| Freund, S | 1 |
| Andreesen, R | 1 |
1 trial available for rofecoxib and Histiocytic Sarcoma
| Article | Year |
|---|---|
Anti-inflammatory and angiostatic therapy in chemorefractory multisystem Langerhans' cell histiocytosis of adults.
Topics: Adult; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Proto | 2005 |